Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jun 10;32(17):1851-2.
doi: 10.1200/JCO.2013.54.4247. Epub 2014 Apr 28.

Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?

Mark J Brenner  1 , Irving D Kaplan  2
Affiliations
Comment

Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?

Mark J Brenner et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to M.J. Brenner et al and I.R. Vogelius et al.
    Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, Stoyanova R, Movsas B, Greenberg RE, Uzzo RG, Ma C, Buyyounouski MK. Pollack A, et al. J Clin Oncol. 2014 Jun 10;32(17):1853-4. doi: 10.1200/JCO.2013.54.7729. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778402 No abstract available.

Comment on

References

    1. Pollack A, Walker G, Horwitz EM, et al. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol. 2013;31:3860–3868. - PMC - PubMed
    1. Lee WR. Prostate cancer and the hypofractionation hypothesis. J Clin Oncol. 2013;31:3849–3851. - PubMed
    1. Katz A, Freeman D, Aronovitz J, et al. Five-year biochemical control rates for stereotactic body radiation therapy for organ-confined prostate cancer: A multi-institutional pooled analysis. Int J Radiat Oncol Biol Phys. 2012;84(suppl):S147–S148.
    1. Meier R, Kaplan I, Beckman A, et al. Stereotactic body radiation therapy for intermediate-risk organ-confined prostate cancer: Interim toxicity and quality of life outcomes from a multi-institutional study. Int J Radiat Oncol Biol Phys. 2012;84(suppl):S148.
    1. Katz AJ, Santoro M, Diblasio F, et al. Stereotactic body radiotherapy for localized prostate cancer: Disease control and quality of life at 6 years. Radiat Oncol. 2013;8:118–125. - PMC - PubMed